Apimeds Pharmaceuticals US, Inc. (APUS) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-21 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-08-06 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-07-13 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-05 | 8-K | Officer / Director Changes | SEC |
| 2026-05-04 | 8-K | Material Agreement, Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2026-04-22 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2026-04-16 | 8-K | Other Events | SEC |
| 2026-03-26 | 8-K | Officer / Director Changes, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-25 | 8-K | Officer / Director Changes, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-16 | 8-K | Other Events | SEC |
| 2026-01-02 | 8-K | Officer / Director Changes | SEC |
| 2025-12-10 | 8-K | Officer / Director Changes | SEC |
| 2025-12-02 | 8-K | Material Agreement, Acquisition or Disposition, Direct Financial Obligation, Unregistered Sales, Change in Control, Officer / Director Changes, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-18 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-10-16 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-07-16 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-05 | 8-K | Officer / Director Changes | SEC |
| 2025-05-20 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-05-12 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-04-15 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.